Fifty-one Kaposi sarcoma patients

Dogan M., Dogan L., ÖZDEMİR F., Ozdemir N. Y., COŞKUN H. Ş., Arslan U. Y., ...More

CLINICAL & TRANSLATIONAL ONCOLOGY, vol.12, no.9, pp.629-633, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 9
  • Publication Date: 2010
  • Doi Number: 10.1007/s12094-010-0568-7
  • Journal Name: CLINICAL & TRANSLATIONAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.629-633
  • Keywords: Kaposi sarcoma, Treatment of Kaposi sarcoma, Chemotherapy in Kaposi sarcoma, Interferon in Kaposi sarcoma, ASSOCIATION, MULTICENTER, PACLITAXEL, RISK
  • Karadeniz Technical University Affiliated: Yes

Abstract

Kaposi sarcoma (KS) is a mesenchymal tumor originating from lymphatic endothelial cells. Immunsupressive patients have higher risk for KS. HHV-8 has a role in immunpathogenesis of KS.